Kidswell Bio Corporation (TYO:4584)
Japan flag Japan · Delayed Price · Currency is JPY
245.00
-3.00 (-1.21%)
At close: Feb 6, 2026

Kidswell Bio Revenue

Kidswell Bio had revenue of 1.56B JPY in the quarter ending September 30, 2025, with 22.76% growth. This brings the company's revenue in the last twelve months to 6.61B, up 321.22% year-over-year. In the fiscal year ending March 31, 2025, Kidswell Bio had annual revenue of 5.08B with 223.90% growth.

Revenue (ttm)
6.61B
Revenue Growth
+321.22%
P/S Ratio
1.84
Revenue / Employee
178.62M
Employees
37
Market Cap
12.15B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20255.08B3.51B223.90%
Mar 31, 20221.57B573.00M57.53%
Mar 31, 2021996.00M-81.00M-7.52%
Mar 31, 20201.08B55.30M5.41%
Mar 31, 20191.02B-38.02M-3.59%
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CellSource3.71B
StemCell Institute2.72B
ReproCELL2.63B
Immuno-Biological Laboratories1.01B
MEDINET998.00M
Stella Pharma992.00M
CellSeed161.00M
Nano Holdings142.00M
Revenue Rankings